Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Should you need assistance, please signal a conference specialist ...

IFGL Refractories Ltd. ( ($IN:IFGLEXPOR) ) just unveiled an update. IFGL Refractories Ltd. announced the approval of its unaudited financial ...

The recovery of gold is indeed influenced by the mineralogical characteristics of the material and the operational conditions employed. For example, Bidari & Aghazadeh (2018) conducted alkaline ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global marketFirst-in-human Phase 1/1b single/multiple dose study in ...

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...

The committee reviewed data showing a 94 percent complete response rate as a third- or later-line treatment for refractory follicular lymphoma.

Drawing on 35 years of experience in the development and production of high-temperature ceramic fibre, RATH is always looking ...

Drawing on 35 years of experience in the development and production of high-temperature ceramic fibre, RATH is always looking for innovative ways to develop new, pioneering product solutions for ...

In a report released yesterday, Carlos De Alba from Morgan Stanley maintained a Buy rating on United States Steel (X – Research Report), with a ...

Mesoblast's RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD ... and actual results may differ from the results anticipated in these ...

Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...